
Japan Asia Investment
Description
Japan Asia Investment Co., Ltd. (JAIC) is a venerable venture capital firm based in Tokyo, Japan, with a rich history spanning over four decades. Established in 1981, JAIC has positioned itself as a key player in supporting both nascent venture companies and established small and medium-sized enterprises (SMEs) across various stages of their development. The firm's long-standing presence in the market underscores its deep experience and commitment to fostering innovation and growth within the Japanese and broader Asian economies.
JAIC employs a comprehensive investment strategy, targeting companies from seed to growth stages, and also engaging in private equity, buyout, and mezzanine financing. Their sector focus is broad, encompassing critical areas such as Information Technology (IT), Healthcare, Environment/Energy, and New Materials. A distinctive aspect of JAIC's approach is its emphasis on long-term support for its portfolio companies, extending beyond capital injection to include management advisory, M&A support, and IPO preparation. This holistic support system is designed to help companies achieve sustainable growth and market leadership.
Over its extensive operational history, JAIC has demonstrated significant scale and reach. The firm has managed an impressive portfolio of over 100 funds, reflecting its robust fundraising capabilities and diverse investment mandates. Furthermore, JAIC boasts an expansive investment record, having participated in over 1,000 investments both within Japan and across various international markets, particularly in Asia. This global footprint is supported by a network of offices in major Japanese cities, as well as key Asian hubs like Beijing, Shanghai, Singapore, and Jakarta, alongside a presence in Silicon Valley, highlighting its commitment to cross-border opportunities.
Investor Profile
Japan Asia Investment has backed more than 21 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 5% of its total and boasts 20 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Japan, China.
- Strong thematic focus on Biotechnology, Biopharma, Health Diagnostics.
- Typical check size: $200K – $7M.
Stage Focus
- Series B (48%)
- Series C (29%)
- Series Unknown (5%)
- Series F (5%)
- Seed (5%)
- Series D (5%)
- Series A (5%)
Country Focus
- United States (67%)
- Japan (29%)
- China (5%)
Industry Focus
- Biotechnology
- Biopharma
- Health Diagnostics
- Manufacturing
- Hardware
- Health Care
- Medical
- Data Storage
- Electronics
- Semiconductor
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.